Vivanza Biosciences Board Meeting on Aug 17 to Approve FY26 Reports
Vivanza Biosciences Ltd has announced a Board of Directors meeting scheduled for August 17, 2026. The primary agenda items include the consideration and approval of the Director's Report and Secretarial Audit Report for FY 2025-26. The board will also discuss and approve the convening of the 44th Annual General Meeting (AGM), appoint a scrutinizer for e-voting, and fix the 'Cut-Off Date' for the AGM as September 04, 2026. Additionally, proposals for adopting amended Memorandum and Articles of Association, seeking member approval for proposed borrowings under Section 180(1)(c), transactions under Section 185, and investments/loans/guarantees under Section 186 of the Companies Act, 2013 will be considered.
Key Highlights
- Board meeting scheduled for August 17, 2026.
- Approval of Director's Report and Secretarial Audit Report for FY 2025-26.
- Convening of 44th Annual General Meeting and related approvals.
- Consideration of proposals for borrowings and investments under Companies Act.
- Fixing September 04, 2026 as the cut-off date for AGM.
Price Impact
More from VIVANZA